Triplet Therapy in Metastatic Clear Cell Renal Cell Carcinoma: Time to Abandon Empiric, Biomarker-unselected

Javier Molina-Cerrillo1, Victoria Gómez Dos Santos2, Teresa Alonso-Gordoa1

  • 1Medical Oncology Department, Hospital Ramón y Cajal, Madrid, Spain; ARON Research Foundation ETS, Macerata, Italy.

European Urology Oncology
|September 21, 2026
PubMed